Development of a prediction model for radiotherapy response among patients with head and neck squamous cell carcinoma based on the tumor immune microenvironment and hypoxia signature
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4791
Abstract: The immune system and hypoxia are major factors influencing radiosensitivity in patients with different cancer types. This study aimed at developing a model to predict radiotherapy response in patients with head and neck squamous cell… read more here.
Keywords: radiotherapy response; patients head; cell carcinoma; head neck ... See more keywords
CD44 variant 6 is associated with prostate cancer growth and chemo-/radiotherapy response in vivo.
Sign Up to like & getrecommendations! Published in 2020 at "Experimental cell research"
DOI: 10.1016/j.yexcr.2020.111850
Abstract: We have previously demonstrated that CD44 variant 6 (CD44v6) is associated with prostate cancer (CaP) growth and therapeutic resistance in vitro, however, the role of CD44v6 in CaP in vivo is not fully understood. The… read more here.
Keywords: radiotherapy response; cd44v6; growth chemo; chemo radiotherapy ... See more keywords
Repeated diffusion MRI reveals earliest time point for stratification of radiotherapy response in brain metastases.
Sign Up to like & getrecommendations! Published in 2017 at "Physics in medicine and biology"
DOI: 10.1088/1361-6560/aa5249
Abstract: An imaging biomarker for early prediction of treatment response potentially provides a non-invasive tool for better prognostics and individualized management of the disease. Radiotherapy (RT) response is generally related to changes in gross tumor volume… read more here.
Keywords: brain metastases; response brain; radiotherapy response; diffusion ... See more keywords
Abstract 1879: Serum biomarker candidates for predicting radiotherapy response in glioblastoma
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Research"
DOI: 10.1158/1538-7445.am2025-1879
Abstract: Glioblastoma remains an incurable disease with limited treatment options. Imaging remains the primary diagnostic tool, but it has limitations in distinguish tumor progression from benign events like pseudoprogression. Currently, no biomarkers exist to differentiate these… read more here.
Keywords: radiotherapy response; serum; progression; response ... See more keywords